These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
212 related items for PubMed ID: 26428372
21. Proteasomal inhibition triggers viral oncoprotein degradation via autophagy-lysosomal pathway. Gain C, Malik S, Bhattacharjee S, Ghosh A, Robertson ES, Das BB, Saha A. PLoS Pathog; 2020 Feb; 16(2):e1008105. PubMed ID: 32092124 [Abstract] [Full Text] [Related]
22. Nuclear receptors and their role in Epstein -- Barr virus induced B cell transformation. Yenamandra SP, Klein G, Kashuba E. Exp Oncol; 2009 Jun; 31(2):67-73. PubMed ID: 19550394 [Abstract] [Full Text] [Related]
23. Functional interplay of Epstein-Barr virus oncoproteins in a mouse model of B cell lymphomagenesis. Sommermann T, Yasuda T, Ronen J, Wirtz T, Weber T, Sack U, Caeser R, Zhang J, Li X, Chu VT, Jauch A, Unger K, Hodson DJ, Akalin A, Rajewsky K. Proc Natl Acad Sci U S A; 2020 Jun 23; 117(25):14421-14432. PubMed ID: 32522871 [Abstract] [Full Text] [Related]
24. Epstein-Barr virus latent gene sequences as geographical markers of viral origin: unique EBNA3 gene signatures identify Japanese viruses as distinct members of the Asian virus family. Sawada A, Croom-Carter D, Kondo O, Yasui M, Koyama-Sato M, Inoue M, Kawa K, Rickinson AB, Tierney RJ. J Gen Virol; 2011 May 23; 92(Pt 5):1032-1043. PubMed ID: 21248177 [Abstract] [Full Text] [Related]
25. Regulation of B cell receptor signalling by Epstein-Barr virus nuclear antigens. Khasnis S, Veenstra H, McClellan MJ, Ojeniyi O, Wood CD, West MJ. Biochem J; 2022 Dec 09; 479(23):2395-2417. PubMed ID: 36383217 [Abstract] [Full Text] [Related]
26. Epstein-Barr virus subverts mevalonate and fatty acid pathways to promote infected B-cell proliferation and survival. Wang LW, Wang Z, Ersing I, Nobre L, Guo R, Jiang S, Trudeau S, Zhao B, Weekes MP, Gewurz BE. PLoS Pathog; 2019 Sep 09; 15(9):e1008030. PubMed ID: 31518366 [Abstract] [Full Text] [Related]
27. EBNA3B-deficient EBV promotes B cell lymphomagenesis in humanized mice and is found in human tumors. White RE, Rämer PC, Naresh KN, Meixlsperger S, Pinaud L, Rooney C, Savoldo B, Coutinho R, Bödör C, Gribben J, Ibrahim HA, Bower M, Nourse JP, Gandhi MK, Middeldorp J, Cader FZ, Murray P, Münz C, Allday MJ. J Clin Invest; 2012 Apr 09; 122(4):1487-502. PubMed ID: 22406538 [Abstract] [Full Text] [Related]
28. Two Epstein-Barr virus (EBV) oncoproteins cooperate to repress expression of the proapoptotic tumour-suppressor Bim: clues to the pathogenesis of Burkitt's lymphoma. Anderton E, Yee J, Smith P, Crook T, White RE, Allday MJ. Oncogene; 2008 Jan 17; 27(4):421-33. PubMed ID: 17653091 [Abstract] [Full Text] [Related]
29. Epstein-Barr virus BamHI W repeat number limits EBNA2/EBNA-LP coexpression in newly infected B cells and the efficiency of B-cell transformation: a rationale for the multiple W repeats in wild-type virus strains. Tierney RJ, Kao KY, Nagra JK, Rickinson AB. J Virol; 2011 Dec 17; 85(23):12362-75. PubMed ID: 21957300 [Abstract] [Full Text] [Related]
30. Contributions of the Epstein-Barr virus EBNA1 protein to gastric carcinoma. Sivachandran N, Dawson CW, Young LS, Liu FF, Middeldorp J, Frappier L. J Virol; 2012 Jan 17; 86(1):60-8. PubMed ID: 22013060 [Abstract] [Full Text] [Related]
31. Epstein-Barr Virus B Cell Growth Transformation: The Nuclear Events. Zhao B. Viruses; 2023 Mar 24; 15(4):. PubMed ID: 37112815 [Abstract] [Full Text] [Related]
32. Epstein-Barr Virus Episome Physically Interacts with Active Regions of the Host Genome in Lymphoblastoid Cells. Wang L, Laing J, Yan B, Zhou H, Ke L, Wang C, Narita Y, Zhang Z, Olson MR, Afzali B, Zhao B, Kazemian M. J Virol; 2020 Nov 23; 94(24):. PubMed ID: 32999023 [Abstract] [Full Text] [Related]
33. The F-box E3 ligase protein FBXO11 regulates EBNA3C-associated degradation of BCL6. Sun K, Bose D, Singh RK, Pei Y, Robertson ES. J Virol; 2024 Jul 23; 98(7):e0054824. PubMed ID: 38864622 [Abstract] [Full Text] [Related]
34. Epstein-Barr virus nuclear antigen 3C interact with p73: Interplay between a viral oncoprotein and cellular tumor suppressor. Sahu SK, Mohanty S, Kumar A, Kundu CN, Verma SC, Choudhuri T. Virology; 2014 Jan 05; 448():333-43. PubMed ID: 24314664 [Abstract] [Full Text] [Related]
35. Pim kinases are upregulated during Epstein-Barr virus infection and enhance EBNA2 activity. Rainio EM, Ahlfors H, Carter KL, Ruuska M, Matikainen S, Kieff E, Koskinen PJ. Virology; 2005 Mar 15; 333(2):201-6. PubMed ID: 15721354 [Abstract] [Full Text] [Related]
36. The amino-terminal domains of Epstein-Barr virus nuclear proteins 3A, 3B, and 3C interact with RBPJ(kappa). Robertson ES, Lin J, Kieff E. J Virol; 1996 May 15; 70(5):3068-74. PubMed ID: 8627785 [Abstract] [Full Text] [Related]
37. Expression profile of nuclear receptors upon Epstein -- Barr virus induced B cell transformation. Yenamandra SP, Lundin A, Arulampalam V, Yurchenko M, Pettersson S, Klein G, Kashuba E. Exp Oncol; 2009 Jun 15; 31(2):92-6. PubMed ID: 19550398 [Abstract] [Full Text] [Related]
38. Requirement for PRC1 subunit BMI1 in host gene activation by Epstein-Barr virus protein EBNA3C. Paschos K, Bazot Q, Lees J, Farrell PJ, Allday MJ. Nucleic Acids Res; 2019 Apr 08; 47(6):2807-2821. PubMed ID: 30649516 [Abstract] [Full Text] [Related]
39. Epstein-Barr virus-associated Burkitt lymphomagenesis selects for downregulation of the nuclear antigen EBNA2. Kelly G, Bell A, Rickinson A. Nat Med; 2002 Oct 08; 8(10):1098-104. PubMed ID: 12219084 [Abstract] [Full Text] [Related]